Skeletal Muscle Loss and Octogenarian Status Are Associated with S-1 Adjuvant Therapy Discontinuation and Poor Prognosis after Pancreatectomy

Skeletal Muscle Loss and Octogenarian Status Are Associated with S-1 Adjuvant Therapy Discontinuation and Poor Prognosis after Pancreatectomy

The efficacy and prognosis of adjuvant chemotherapy for resected pancreatic cancer remain unclear. We investigated the utility and risk factors of S-1 adjuvant chemotherapy in patients with pancreatic cancer undergoing pancreatectomy. This study comprised 80 patients, including 58 patients who recei...

Full description

Bibliographic Details
Main Authors: Mariko Tsukagoshi, Norifumi Harimoto, Kenichiro Araki, Norio Kubo, Akira Watanabe, Takamichi Igarashi, Norihiro Ishii, Takahiro Yamanaka, Kei Hagiwara, Kouki Hoshino, Ryo Muranushi, Toshiki Yajima, Ken Shirabe
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cancers
Subjects:
adjuvant chemotherapy
elderly patients
outcome
pancreatic cancer
sarcopenia
Online Access:https://www.mdpi.com/2072-6694/13/16/4105

Internet

https://www.mdpi.com/2072-6694/13/16/4105

Similar Items